Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium.
Cnossen VM, Moreira PCL, Engelhardt OG, Samolej J, Groeneveld GH, Jochems SP, Huisman W, Pedersen GK, Wørzner K, Recek L, Piccini G, Trombetta CM, Aspelund A, Hoag A, Reiter M, Wick C, Muster T, Kamerling IMC. Cnossen VM, et al. Among authors: groeneveld gh. Front Immunol. 2025 May 23;16:1568778. doi: 10.3389/fimmu.2025.1568778. eCollection 2025. Front Immunol. 2025. PMID: 40486504 Free PMC article.
A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Influenza Among Immunocompromised Adults With a Solid Organ Transplant.
Prins MLM, van Dokkum ED, de Vries APJ, Tushuizen ME, van der Helm D, Spithoven EM, van der Meer IM, Groeneveld JHM, Visser LG, le Cessie S, Vollaard AM, Groeneveld GH. Prins MLM, et al. Among authors: groeneveld gh. Transpl Int. 2025 May 16;38:14187. doi: 10.3389/ti.2025.14187. eCollection 2025. Transpl Int. 2025. PMID: 40454297 Free PMC article.
CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.
Gorbenko AA, Heuberger JAAC, Juachon M, Klaassen E, Tagen M, Lawler JF, Schneeberger D, Cundy KC, Klumpers LE, Groeneveld GJ. Gorbenko AA, et al. Among authors: groeneveld gj. Clin Pharmacol Ther. 2025 May;117(5):1427-1436. doi: 10.1002/cpt.3581. Epub 2025 Feb 3. Clin Pharmacol Ther. 2025. PMID: 39898464 Free PMC article. Clinical Trial.
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort Study.
Swets MC, Kerr SR, MacKenna B, Fisher L, van Wijnen M, Brandwagt D, Schenk PW, Fraaij P, Visser LG, Bacon S, Mehrkar A, Nichol A, Twomey P, Matthews PC; ISARIC4C Hepatitis Study Group; Semple MG, Groeneveld GH, Goldacre B, Jones I, Baillie JK. Swets MC, et al. Among authors: groeneveld gh. JMIR Public Health Surveill. 2024 Dec 23;10:e55376. doi: 10.2196/55376. JMIR Public Health Surveill. 2024. PMID: 39864403 Free PMC article.
Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.
Ruijs TQ, de Cuba CMKE, Heuberger JAAC, Hutchison J, Bold J, Grønnebæk TS, Jensen KG, Chin E, Quiroz JA, Petersen TK, Flagstad P, de Kam ML, van Esdonk MJ, Klaassen E, Doll RJ, Koopmans IW, de Goede AA, Aulin LBS, Pedersen TH, Groeneveld GJ. Ruijs TQ, et al. Among authors: groeneveld gj. Clin Pharmacol Ther. 2025 Mar;117(3):768-778. doi: 10.1002/cpt.3516. Epub 2024 Dec 9. Clin Pharmacol Ther. 2025. PMID: 39651850 Free PMC article. Clinical Trial.
TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects.
de Cuba CMKE, de Goede AA, Klaassen ES, Otto ME, Doll RJ, Kim J, Demitrack MA, Chen R, Groeneveld GJ, Heuberger JAAC. de Cuba CMKE, et al. Among authors: groeneveld gj. Clin Pharmacol Ther. 2025 Mar;117(3):787-797. doi: 10.1002/cpt.3521. Epub 2024 Dec 6. Clin Pharmacol Ther. 2025. PMID: 39641417 Free PMC article. Clinical Trial.
Open-Label Interventional Study in Healthy Volunteers to Evaluate NO-Mediated Vasodilation by Dermal Allyl Isothiocyanate Challenge and Whole-Body Heat Stress.
van Ruissen MCE, van Kraaij SJW, Gal P, Bakker WA, Hijma HJ, Groeneveld GJ, de Kam ML, Burggraaf J, Moerland M. van Ruissen MCE, et al. Among authors: groeneveld gj. J Exp Pharmacol. 2024 Sep 17;16:285-294. doi: 10.2147/JEP.S473217. eCollection 2024. J Exp Pharmacol. 2024. PMID: 39308849 Free PMC article. Clinical Trial.
210 results